SONIC News & Analysis

Schroders' Australian equity team say investors piling into tech stocks again are ignoring a turning point in markets.

Two health stocks and an Australian property group were among the notable ASX purchases made by fund managers in recent months.

The $8.6bn promised for the healthcare means more scrutiny on insurance premiums and rebates and more pressure on insurers such as Medibank and NIB.

Biotech stock Cochlear has kicked off the next phase of implant technology as the healthcare sector takes a tumble.